Little Green Pharma
Little Green Pharma is a leading global medicinal cannabis business with key production in Australia and Denmark (EU). A pioneer and innovator in Australian-grown, manufactured and exported medicinal cannabis for therapeutic use. Little Green Pharma brings together nature and science, with the company aiming to provide targeted and natural therapeutic solutions that transform the lives of patients globally.
In 2020, HIF was the first major Australian health fund to publicly support access to medicinal cannabis treatments.
HIF partners with Little Green Pharma to fund the QUEST research initiative, which is now demonstrating the scientific evidence about the positive impacts of medicinal cannabis on a range of debilitating health conditions. Pleasingly, the study is uncovering clinically meaningful improvements in health-related quality of life, fatigue, and sleep disorders.
HIF will continue to pay benefits for medicinal cannabis across the majority of our Extras policies.
Read QUEST initiative here